Florida Trial Sites

Cleveland Clinic Florida’s Maroone Cancer Center provides world-class care to patients with cancer and is at the forefront of new and emerging cancer research. Cleveland Clinic Florida’s cancer program is nationally recognized as High Performing by U.S. News & World Report 2017-18 “Best Hospitals” Miami-Fort Lauderdale metropolitan area ranking. By harnessing the benefits of advanced research and technology,… read more //

EmergingMed – Our clinical trial database includes all treatment trials from clinicaltrials.gov along with updates reported to us directly by trial sponsors and sites.

Florida Cancer Specialists & Research Institute (FCS) is committed to participating in the latest research, in order to find new and better treatments for patients. Their goal is to give patients access to the latest investigational therapies without having to travel long distances. FCS has 35 locations that directly participate in clinical trials. These sites… read more //

Moffitt Cancer Center is the home of Florida’s largest clinical cancer research unit, with more than 450 active trials exploring new medical discoveries or new ways to use existing treatments. Clinical trials offer participants unique opportunities to be among the first to benefit from recent scientific progress that has the potential to enhance both outcomes… read more //

UF Health Cancer Center. Hundreds of scientists, clinicians, research assistants, nurses, technicians and staff come together every day within the most comprehensive academic medical center in the Southeast to investigate and analyze new information and to channel their discoveries into better therapies for cancer patients.

The University of Miami Sylvester Comprehensive Cancer Center (SCCC)  offers a portfolio of approximately 200 cancer clinical trials to patients from South Florida and around the world.  These trials offer innovative treatment options to patients with all types of tumors.  Many of the trials are tailored to specific mutations found on analysis of a patient’s… read more //

Evaluating the effect of givosiran (ALN-AS1) on the rate of porphyria attacks in patients with Acute Hepatic Porphyrias (AHP). Trial Status: Enrolling Interested in learning more? Please email us at [email protected] For more info: ClinicalTrials.gov – NCT03338816

A Phase II/III Randomized Trial of VELIPARIB or PLACEBO in combination with  adjuvant TEMOZOLOMIDE in newly diagnosed Glioblastoma with MGMT promoter Hypermethyation.   Coordinator’s Contact Info: Tresalynn 786-296-9310 MSMC ONLY

The main purpose of this study is to determine the safe and recommended dose of APR-246 in combination with azacitidine as well as to see if this combination of therapy improves overall survival. Please visit our clinical trials website here.

Phase II Trial of SMO/AKT/NF2 inhibitors in Progressive Meningioma’s with SMO/AKT/NFT2 Mutations.   Coordinator’s Contact Info: Mayra/Lisandra 305-519-2147 MSMC ONLY  

Sanofi Genzyme is currently looking for sites to participate in the feasibility for an upcoming Sanofi Genzyme study to assess a diagnostic protocol for individuals with unexplained splenomegaly and thrombocytopenia. This study will determine the prevalence of Gaucher Disease and Acid Sphingomyelinase Deficiency (Niemann-Pick A and B) among individuals with splenomegaly and thrombocytopenia who meet additional inclusion… read more //